Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference34 articles.
1. Association for Accessible Medicines. Generic drug access & savings in the U.S. 2017. Available at:
http://accessiblemeds.org/sites/default/files/2017-07/2017-AAM-Access-Savings-Report-2017-web2.pdf
. Accessed 27 Oct 2017.
2. MedWatch: the FDA safety information and adverse event reporting program. Available at:
https://www.fda.gov/Safety/MedWatch/default.htm
. Accessed 1 Feb 2018.
3. Shin JW, Chu K, Jung KH, Lee ST, Moon J, Lee SK. Switching between phenytoin generics in patients with epilepsy may lead to increased risk of breakthrough seizure: chart analysis and practice recommendations. Int J Clin Pharmacol Ther. 2014;52:1017–22.
4. Andermann F, Duh MS, Gosselin A, Paradis PE. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia. 2007;48:464–9.
5. LeLorier J, Duh MS, Paradis PE, et al. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy. Neurology. 2008;70(22 Pt 2):2179–86.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献